The global Mental Health Screening Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Software, Services, Wearables, Mobile and Other Devices, Physiological Disorders, Psychiatric Disorders, Behavioral Disorders, Cognitive Disorders), By Screening Method (Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, Biomarker Testing), By Technology (Self-screening mHealth Apps, Telehealth & Virtual Care Solutions, Continuous Monitoring Wearable Devices, AI-based Screening Tools, Remote Mental Health Platforms), By Age Group (Children & Adolescents, Adults, Seniors), By Setting (Clinical Settings, Educational Institutions, Workplace/Corporate Programs, Online Platforms, Others).
The Mental Health Screening Market in 2024 addresses the growing need for early detection, intervention, and management of mental health conditions, offering a range of screening tools and assessments for individuals, healthcare providers, and organizations worldwide. Mental health screening involves the systematic evaluation of individuals' mental and emotional well-being using standardized questionnaires, interviews, and assessments to identify symptoms of mental health disorders such as depression, anxiety, bipolar disorder, and post-traumatic stress disorder (PTSD). The market experiences significant growth driven by factors such as increasing awareness of mental health issues, rising prevalence of mental disorders, and the growing emphasis preventive healthcare and wellness initiatives. Mental health screening solution providers innovate to develop -friendly, scalable, and evidence-based screening tools that enable early intervention, personalized treatment planning, and tracking of treatment outcomes. Additionally, advancements in digital health technologies, telemedicine platforms, and artificial intelligence (AI) algorithms enhance the accessibility, accuracy, and efficiency of mental health screening and assessment processes. Furthermore, collaborations between healthcare organizations, technology developers, and mental health advocates promote awareness, destigmatization, and integration of mental health screening into routine healthcare practices. As societies prioritize mental health promotion and support, the mental health screening market remains essential in facilitating early detection and intervention, reducing the burden of mental illness, and improving overall well-being and quality of life.
The global Mental Health Screening Market Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Mental Health Screening Market Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Mental Health Screening Market Industry include- Adaptive Testing Technologies Inc, Aiberry Inc, Alphabet Inc, Apple Inc, Canary Speech Inc, Clarigent Health, CogniABle., Cognitive Health Solutions Llc, Ellipsis Health Inc, FuturesTHRIVE, Headspace Health, Kintsugi Mindful Wellness Inc, Koninklijke Philips N.V., Modern Life Inc, MoodFit Inc, MoodTools Inc, Proem Behavioral Health, Quartet Health Inc, ResMed Inc, Riverside Community Care, Sonde Health Inc, SonderMind Inc, Thymia Ltd, Wellin5 USA Inc, Woebot Labs Inc
A significant trend in the Mental Health Screening Market is the increasing awareness and acceptance of mental health screening as an essential component of healthcare. With growing recognition of the prevalence and impact of mental health disorders globally, there's a heightened emphasis on early detection and intervention. As a result, individuals, healthcare providers, and organizations are increasingly embracing mental health screening tools and programs to identify mental health issues promptly and facilitate timely access to treatment and support services. This is driving the demand for innovative and accessible mental health screening solutions, leading to market growth and expansion.
A key driver propelling the Mental Health Screening Market is the rising prevalence of mental health disorders and the associated healthcare burden. Mental illnesses such as depression, anxiety, bipolar disorder, and PTSD (post-traumatic stress disorder) affect millions of people worldwide, leading to significant social, economic, and healthcare challenges. As the burden of mental health disorders continues to escalate, there's an urgent need for effective screening tools and strategies to identify individuals at risk and provide timely interventions. Healthcare providers, policymakers, and advocacy groups are driving the adoption of mental health screening initiatives to address the growing demand for mental healthcare services, creating opportunities for market growth and development.
An opportunity in the Mental Health Screening Market lies in the integration of technology and telehealth solutions to enhance accessibility and effectiveness. With the proliferation of digital health technologies, there's potential to leverage mobile apps, wearable devices, artificial intelligence, and telemedicine platforms for remote mental health screening and monitoring. By incorporating these technologies into mental health screening programs, healthcare providers can reach underserved populations, improve patient engagement, and gather real-time data for personalized interventions. Additionally, the integration of telehealth solutions enables seamless communication between patients and providers, facilitating remote consultations, follow-ups, and support services. The opportunity enables companies to innovate and differentiate their offerings in the mental health screening market, addressing evolving patient needs and market demands while driving efficiency and scalability in mental healthcare delivery.
By Application
By Screening Method
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
By Technology
By Age Group
By Setting
Geographical Analysis
*- List not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2024 Mental Health Screening Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Mental Health Screening Market Size Outlook, $ Million, 2021 to 2030
3.2 Mental Health Screening Market Outlook by Type, $ Million, 2021 to 2030
3.3 Mental Health Screening Market Outlook by Product, $ Million, 2021 to 2030
3.4 Mental Health Screening Market Outlook by Application, $ Million, 2021 to 2030
3.5 Mental Health Screening Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Mental Health Screening Industry
4.2 Key Market Trends in Mental Health Screening Industry
4.3 Potential Opportunities in Mental Health Screening Industry
4.4 Key Challenges in Mental Health Screening Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Mental Health Screening Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Mental Health Screening Market Outlook by Segments
7.1 Mental Health Screening Market Outlook by Segments, $ Million, 2021- 2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
8 North America Mental Health Screening Market Analysis and Outlook To 2030
8.1 Introduction to North America Mental Health Screening Markets in 2024
8.2 North America Mental Health Screening Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Mental Health Screening Market size Outlook by Segments, 2021-2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
9 Europe Mental Health Screening Market Analysis and Outlook To 2030
9.1 Introduction to Europe Mental Health Screening Markets in 2024
9.2 Europe Mental Health Screening Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Mental Health Screening Market Size Outlook by Segments, 2021-2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
10 Asia Pacific Mental Health Screening Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Mental Health Screening Markets in 2024
10.2 Asia Pacific Mental Health Screening Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Mental Health Screening Market size Outlook by Segments, 2021-2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
11 South America Mental Health Screening Market Analysis and Outlook To 2030
11.1 Introduction to South America Mental Health Screening Markets in 2024
11.2 South America Mental Health Screening Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Mental Health Screening Market size Outlook by Segments, 2021-2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
12 Middle East and Africa Mental Health Screening Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Mental Health Screening Markets in 2024
12.2 Middle East and Africa Mental Health Screening Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Mental Health Screening Market size Outlook by Segments, 2021-2030
By Application
Software
Services
Wearables
Mobile and Other Devices
Physiological Disorders
Psychiatric Disorders
Behavioral Disorders
Cognitive Disorders
By Screening Method
Self-reported Questionnaires & Surveys
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
Clinical Interviews
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
Observation-based Assessments
Biomarker Testing
By Technology
Self-screening mHealth Apps
Telehealth & Virtual Care Solutions
Continuous Monitoring Wearable Devices
AI-based Screening Tools
Remote Mental Health Platforms
By Age Group
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
By Setting
Clinical Settings
Educational Institutions
Workplace/Corporate Programs
Online Platforms
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
Adaptive Testing Technologies Inc
Aiberry Inc
Alphabet Inc
Apple Inc
Canary Speech Inc
Clarigent Health
CogniABle.
Cognitive Health Solutions Llc
Ellipsis Health Inc
FuturesTHRIVE
Headspace Health
Kintsugi Mindful Wellness Inc
Koninklijke Philips N.V.
Modern Life Inc
MoodFit Inc
MoodTools Inc
Proem Behavioral Health
Quartet Health Inc
ResMed Inc
Riverside Community Care
Sonde Health Inc
SonderMind Inc
Thymia Ltd
Wellin5 USA Inc
Woebot Labs Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Application
By Screening Method
-Beck Depression Inventory (BDI)
-Generalized Anxiety Disorder-7 (GAD-7)
-Patient Health Questionnaire-12 (PHQ-12)
-Hamilton Anxiety Rating Scale (HAM-A)
-Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
-Others
-Structured Clinical Interview for DSM (SCID)
-Mini International Neuropsychiatric Interview (MINI)
-Diagnostic Interview for Psychological Distress (DIPD)
-Others
By Technology
By Age Group
By Setting
Geographical Analysis
The global Mental Health Screening Market is one of the lucrative growth markets, poised to register a 13.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Adaptive Testing Technologies Inc, Aiberry Inc, Alphabet Inc, Apple Inc, Canary Speech Inc, Clarigent Health, CogniABle., Cognitive Health Solutions Llc, Ellipsis Health Inc, FuturesTHRIVE, Headspace Health, Kintsugi Mindful Wellness Inc, Koninklijke Philips N.V., Modern Life Inc, MoodFit Inc, MoodTools Inc, Proem Behavioral Health, Quartet Health Inc, ResMed Inc, Riverside Community Care, Sonde Health Inc, SonderMind Inc, Thymia Ltd, Wellin5 USA Inc, Woebot Labs Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume